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Background: Antimicrobial resistance (AMR) is a major threat to global public health. Medicinal plants have long
been used as remedies for infectious diseases by native cultures around the world and have the potential for
providing effective treatments for antibiotic-resistant infections. Rhamnus californica (Rhamnaceae) and Umbellularia
californica (Lauraceae) are two indigenous California plant species historically used by Native Americans to treat skin,
respiratory and gastrointestinal infections. This study aimed to assess the in vitro antimicrobial activity of methanolic
extracts of leaves and bark of R. and U. californica against methicillin-resistant Staphylococcus aureus (MRSA) and
other Gram-positive and Gram-negative bacteria.
Methods: Methanolic extracts of leaves and bark of R. and U. californica were prepared by soxhlet extraction and
evaluated for their antimicrobial activity against Bacillus cereus, Streptococcus pyogenes, Mycobacterium smegmatis,
Staphylococcus aureus, MRSA, Escherichia coli and Pseudomonas aeruginosa using disc diffusion and minimal
inhibitory concentration (MIC) assays. Chemical profiling of the extracts was performed using standard methods.
Results: All extracts inhibited the growth of MRSA and other Gram-positive bacteria with MICs of 3.3-6.0 mg/ml.
Gram-negative organisms were unaffected by these extracts. U. californica extracts (leaves and bark) had the lowest
MIC values. Chemical profiling detected the presence of quinones, alkaloids, flavonoids, cardenolides, tannins and
saponins in these extracts. Our study is the first to report the antimicrobial properties of R. and U. californica and
illustrates their promising anti-MRSA potential.
Conclusions: Our results give scientific credence to the traditional medicinal uses of these plants by the
indigenous peoples of California. Further investigation of the secondary metabolites responsible for the
antimicrobial activity of these extracts against MRSA is warranted.
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The incidence of infections by antibiotic-resistant bac-
teria has increased significantly over the last decade. In
the U.S., over 90,000 infections per year are caused by
methicillin-resistant Staphylococcus aureus (MRSA)
alone [1]. Antimicrobial resistance (AMR) has also been
found in strains of Streptococcus pneumonia, Escheri-
chia coli, Pseudomonas aeruginosa, and Mycobacterium
tuberculosis, to name a few. The emergence of AMR has* Correspondence: maria.carranza@dominican.edu
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unless otherwise stated.prompted the Centers for Disease Control (CDC) and
the World Health Organization (WHO) to spearhead
efforts aimed at combating this dilemma through public
education about the misuse of antibiotics, increased sur-
veillance, and research focused on developing new, more
effective therapies [2]. For thousands of years native peo-
ples across the globe have used traditional medicine to
treat many human diseases, including infectious diseases
[3]. Native Americans produced traditional medicines from
approximately 2700 species of vascular plants [4]. The me-
dicinal ethnobotanical knowledge of Native Americans has
been an important source for the identification of bioactivel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tween traditional medicinal uses and observed biological
activity [5].
Rhamnus californica (Rhamnaceae) and Umbellularia
californica (Lauraceae) are two indigenous California plant
species historically used by Native Americans for their
medicinal properties [6, 7]. Specifically, R. californica was
used as a decoction of leaves for the treatment of poison
oak dermatitis (Costanoan tribe); crushed leaves and ber-
ries were used to heal infected sores, burns and wounds
(Kawaiisu tribe); and a decoction of bark was used to treat
grippe (Mendocino and Yokia tribes) [4, 8]. Similarly, U.
californica was used as a decoction of leaves and as a
steam bath for the treatment of cold symptoms (Karok,
Pomo and Kashaya tribes); a poultice of leaves was applied
to sores (Karok, Pomo and Kashaya tribes) and used as a
treatment for poison oak dermatitis (Costanoan tribe) [9];
a decoction of leaves was used for sore throat and chest
congestion (Pomo, Kashaya tribes); crushed leaves were
used for nasal decongestion (Yuki tribe); and a decoction
of whole plant was taken for stomachaches (Mendocino
tribe) [4, 8]. Earlier chemical studies reported the presence
of anthraquinones [10, 11] in the genus Rhamnus, while
terpenoids [9, 12], alkaloids [13], and flavonoids [14] are
reported as major constituents of U. californica [15] withFig. 1 Selected examples of reported structural classes from R. californica acyanogens, sugars and tannins as minor constituents [12].
Selected examples of reported structural classes from R.
and U. californica are shown in Fig. 1.
The use of both species in Native American traditional
medicine for the treatment of symptoms associated with
skin, respiratory and gastrointestinal infections provided
a rationale for investigating the in vitro antimicrobial po-
tential of the methanolic extracts of leaves and bark of
Rhamnus californica (Coffeeberry) and Umbellularia cali-
fornica (California bay or California laurel) against MRSA
and other types of Gram-positive and Gram-negative bac-
teria. We are the first to report the antibacterial activity of
extracts from these two species and illustrate their prom-
ising anti-MRSA potential.
Methods
Plant material and extraction
Rhamnus californica and Umbellularia californica were
obtained from the University of California at Berkeley
Botanical Garden (UCBBG). Specimens were authenticated
by Dr. Holly Forbes, curator of the UCBBG. Voucher spec-
imens for each species (50.1622 and 71.0162) have been
deposited at the UC Berkeley Herbarium. Leaves and bark
were separated and oven dried after which they were
grinded into fine powder or shavings. Thimbles werend U. californica
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tracted using a Soxhlet apparatus. The plant materials
were successively extracted with hexanes, dichlorometh-
ane, and methanol (2 × 100 ml for 24 h each). The
resulting extracts were filtered, concentrated under re-
duced pressure, and kept at 4 °C.
Microorganisms tested
All bacterial organisms were purchased from the American
Type Culture Collection (ATCC; Manassas, VA, USA).
Specific strains used were: Bacillus cereus ATCC® 14579™,
Escherichia coli ATCC® 25922™, Mycobacterium smegmatis
ATCC® 10143™, Pseudomonas aeruginosa ATCC® 10145™,
Staphylococcus aureus ATCC® 25923™, methicillin-resistant
Staphylococcus aureus (MRSA) ATCC® BAA-1683™, and
Streptococcus pyogenes ATCC® 10782™.
Disc-diffusion assay
The disc diffusion method developed by Kirby and Bauer
was used with some modifications [16]. Initially, bacterial
cultures were streaked onto tryptic soy agar plates and in-
cubated overnight at 37 °C to obtain individual colonies.
Colonies were then selected and resuspended in tryptic
soy broth to achieve turbidity equal to that of a 0.5 McFar-
land Turbidity standard (BD Biosciences, Franklin Lakes,
NJ, USA). Using a cotton swab, the bacterial suspension
was used to inoculate a Mueller-Hinton agar plate
(Carolina Biological Supply Company, Burlington, NC,
USA). Various doses of plant extracts (all dissolved in
methanol) were applied to 6 mm diameter paper discs
(BD Biosciences), and the discs were then carefully placed
onto the surface of the Mueller-Hinton agar plate. Plates
were incubated at 35 °C for 20–22 h, after which the di-
ameters of the zones of inhibition around each disc were
measured. Streptomycin discs (10 μg; BD Biosciences)
were used as a positive control.
Minimal Inhibitory Concentration (MIC) assay
The microplate method developed by J.N. Eloff was
used, with some modifications, to test the MIC of each
extract for each bacterial species that demonstrated sus-
ceptibility in the Kirby-Bauer assay [17]. Briefly, bacterial
colonies growing on either tryptic soy or brain heart
infusion (BHI) agar plates were selected and resuspended
in Mueller-Hinton broth (Carolina Biological Supply Com-
pany) to achieve turbidity equal to that of a 0.5 McFarland
Turbidity standard. In a 96-well plate, 50 μl aliquots of this
bacterial suspension were mixed with various concentra-
tions of each extract (or methanol, as a negative control)
for a final volume of 100 μl per well. The plate was incu-
bated at 35 °C for 20–22 h. Due to the slow growth of M.
smegmatis, that particular assay plate was incubated for
46–48 h. In order to better visualize bacterial growth,
40 μl of 0.2 mg/ml p-iodonitrotetrazolium violet (INT;Sigma-Aldrich Corp., St. Louis, MO, USA) were then
added to each well, and the plate was incubated at 37 °C
for another 30 min. Wells were analyzed visually for the
development of a reddish hue, which would indicate
bacterial growth.
Chemical profiling
Qualitative detection of alkaloids, flavonoids, leucoantocya-
nidins, cardenolides, tannins, saponins, steroids and qui-
nones was performed using standard procedures [18–21].
Each assay was performed in triplicate.
Results
Antimicrobial activity
The antimicrobial activity of the three methanolic ex-
tracts was initially assessed using the Kirby-Bauer disc
diffusion assay. Extract doses ranging from 1 to 25 mg
were tested on the Gram-negative organisms E. coli and P.
aeruginosa and on the Gram-positive bacteria B. cereus, S.
pyogenes, S. aureus, and MRSA. Streptomycin (10 μg/disc)
was used as a positive control, and 100 % methanol, the
extract solvent, was used as negative control. The Gram-
negative bacteria were virtually unaffected by the extracts.
However, all of the Gram-positive bacteria demonstrated
sensitivity to each extract at doses between 1 and 5 mg
(Table 1). Of the three extracts, the one from R. californica
leaves appeared to be the most active. Interestingly, its
greatest effect was seen on the only antibiotic-resistant
strain tested—MRSA.
Minimal Inhibitory Concentration (MIC)
After having determined that all the extracts significantly
inhibited the growth of MRSA and other Gram-positive
organisms, minimal inhibitory concentration (MIC) assays
were performed (Table 2). Due to difficulty culturing S.
pyogenes within the 96-well plate, the MIC assay could not
be carried out on this organism. For the remaining four
organisms, MIC values ranged between 3.3 and 6.0 mg/
ml. B. cereus exhibited the greatest sensitivity to the three
extracts, and MRSA predictably required slightly higher
concentrations to inhibit growth. Although difficulty in
growing a lawn of M. smegmatis prevented it from being
tested using the Kirby-Bauer assay, the MIC assays dem-
onstrated that even this acid-fast organism was susceptible
to the extracts. Additionally, according to these MIC data,
the U. californica extracts, rather than the R. californica
extract, appeared to be most active.
Chemical profiling
Alkaloids, flavonoids, cardenolides and saponins were de-
tected in the methanolic extracts of R. californica leaves
and U. californica leaves and bark. Leucoanthocyanidins
were detected in both U. californica leaves and bark but
not in R. californica leaves. Tannins were detected in the
Table 1 Antimicrobial activity of methanolic extracts of R. californica and U. californica analyzed by Kirby-Bauer disc-diffusion assay
Bacterial Strains
Diameter of Zone of Inhibition (mm)













Leaves 1 10.0 ± 2.1 -- -- -- 10.0 9.0
5 12.3 ± 0.5 -- -- 11.0 ± 1.2** 15.0 12.0
10 13.0 ± 0.0 -- -- 12.5 ± 2.1Ψ 16.0 14.0
25 14.3 ± 0.5 -- -- 14.0 ± 1.4** n.t. n.t.
U. californica
Leaves 1 9.0 ± 0.0 -- -- -- 8.0 8.0
5 9.5 ± 0.5 -- -- 9.3 ± 1.0** 9.0 11.0
10 9.3 ± 0.5 -- -- 10.5 ± 1.4Ψ 10.0 15.0
25 10.0 ± 0.0 -- -- 10.9 ± 2.0** n.t. n.t.
Bark 1 -- -- -- 8.0 ± 0.0Ψ -- --
5 9.3 ± 0.5 -- -- 12.8 ± 2.6** 9.0 8.0
10 10.3 ± 0.5 -- -- 17.5 ± 1.4Ψ 10.0 11.0
25 11.7 ± 0.5 -- -- 16.0 ± 1.2** n.t. n.t.
Streptomycin 0.01 23.8 ± 1.2 19.8 ± 0.2 10.4 ± 0.3 18.9 ± 1.0 17.0 ± 0.0 18.0 ± 0.0
Methanol 100 % -- -- -- -- -- --
Data represented as averages ± SD. --, no significant zone of inhibition; n.t., not tested; 1, n = 1; Ψ, n = 2; **, n = 4; remaining data (B. cereus, E. coli, and P. aeruginosa)
represent sample size of 3 (n = 3)
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U. californica. Steroids were only detected in the bark of
U. californica but not in the leaves of U. or R. californica.
Finally, quinones were detected only in the leaves of R.
Californica (Table 3).
Discussion
Despite the alarming rise in AMR over the last several
years, resistance to antimicrobial drugs is nothing new.
In 1945— two years after the mass-production of penicil-
lin— over 20 % of S. aureus strains isolated from hospital-
ized patients were penicillin-resistant [22]. Subsequent
antibiotics such as streptomycin, tetracycline, methicillin,
cephalothin, gentamicin, cefotaxime, and linezolid all
followed suit, resulting in the emergence of resistant bac-
terial strains one to four years after their introduction
[22]. History indicates that for every new antimicrobial
drug developed, a proportion of bacteria will become re-
sistant to it and pose a greater threat to public health.Table 2 Minimum inhibitory concentration (MIC) of methanolic extr
Plants B. cereus ATCC® 14579 S. aureus ATCC® 2
R. californica Leaves 4.0 ± 0 6.0 ± 0*
U. californica Leaves 4.0 ± 0 4.3 ± 0.5
U. californica Bark 3.3 ± 1.2 4.0 ± 0
Methanol -- --
Values represent averages ± SD. –, not active; most experiments were repeated threTherefore, alternative strategies must be considered if
antimicrobial resistance is to be successfully combated.
One alternative is the use of medicinal plants, which for
many cultures continue to play a crucial role in the pri-
mary care of patients [3]. In fact, the World Health
Organization supports combining western with traditional
medicinal practices in order to develop truly effective rem-
edies for our modern health challenges [23].
It is widely accepted that the antimicrobial activities
and physiological effects from plant therapies are due to
the biosynthesis of secondary metabolites produced by
plants as a defense mechanism [24]. Very limited chem-
ical profiling work has been done on R. californica (as
mentioned previously, earlier chemical studies reported
the presence of anthraquinones [10, 11] in the genus
Rhamnus), while terpenoids [9, 12], alkaloids [13], and fla-
vonoids [14] are reported as major constituents of U. cali-
fornica [15] with cyanogens, sugars and tannins as minor
constituents [12]. Our study is the first to detect theacts of R. californica and U. californica (mg/ml)
5923 MRSA ATCC® BAA-1683 M. smegmatis ATCC® 10143
6.0 ± 0* 5.0 ± 1.4*
5.5 ± 1.0* 4.7 ± 1.2
5.0 ± 1.4* 6.0 ± 2.1
-- --
e times (n = 3); *n = 2
Table 3 Extract yield and chemical profile of methanolic
extracts of R. californica and U. californica
Plants
R. californica U. californica
Leaves Leaves Bark
Extract Yield (% w/w) 13.9 28.9 5.75
Alkaloids + + +
Flavonoids + + +
Leucoanthocyanidins - + +
Cardenolides + + +
Tannins + + -
Saponins + + +
Steroids - - +
Quinones + - -
+, present; −, absent
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lides, tannins and saponins in R. californica (leaves). In
addition, alkaloids, flavonoids, cardenolides, saponins,
tannins (leaves), and steroids (bark) were detected in U.
californica. Individually, each of these classes of com-
pounds varies considerably in antimicrobial capacity
[25]. At the same time, some of the structural classes
found in R. and U. californica have recently shown prom-
ising anti-MRSA potential. Specifically, a structural analog
of the anthraquinone emodin, found in the genus Rham-
nus, and a novel class of synthetic antibacterial cationic
anthraquinones have shown potent antibacterial effects
against MRSA [26, 27]. Likewise, structural analogs of fla-
vonoids kaempferol, quercetin and eriodictyol [28], found
in U. californica, and plant extracts containing terpenoids
umbellulone, 1,8-cineole, α-terpineol and thymol among
others [29–31] have shown anti-MRSA activity. Inter-
estingly, even though 1,8-cineole exhibits little inherent
antimicrobial activity, it has been shown to enhance the
potency of other antimicrobials against MRSA [31].
Therefore, it is likely that the antimicrobial activity ob-
served herein is due to the synergistic effects of all or
most of the secondary metabolites present in each ex-
tract [31, 32]. In addition, the many compounds in the
extracts may affect the bacteria via several different
mechanisms, thus decreasing the likelihood of selecting
for a resistant strain.
Our study is the first to report the antimicrobial potential
of the methanolic extracts of leaves and bark of R. califor-
nica and U. californica, all of which significantly inhibited
growth of Gram-positive bacteria such as B. cereus, S. pyo-
genes, and S. aureus, as well as the acid-fast organism M.
smegmatis. Most intriguing was the discovery that these
plant extracts were effective at controlling the growth of
MRSA, one of the most ominous AMR strains, with MICs
of 3.3-6.0 mg/ml. While we acknowledge that these MICvalues are relatively high (in comparison to the generally
accepted notion that plant extracts have significant anti-
microbial activity if their MIC values are 100 μg/ml or
lower), the fact that the two Gram-negative organisms E.
coli and P. aeruginosa were virtually unaffected by these
extracts is noteworthy and indicates that the antimicro-
bial effects on the Gram-positive organisms are specific
and thus significant. This complete lack of activity on
the Gram-negative organisms is most likely due to the
protective nature of the outer membrane of their cell
walls. Furthermore, MIC values similar to those ob-
tained in this study have been reported recently by other
researchers, such as: Farooqui et al., who tested the anti-
bacterial activity of C. Sinensis and J. Regia against
multidrug-resistant bacteria including MRSA [33]; Siwe
Noundou et al., who demonstrated the antibacterial activ-
ity of A. floribunda against B. cereus and S. aureus [34];
and Zuo et al., who tested the antibacterial activity of 19
Chinese medicinal plants against MRSA [35]. Interest-
ingly, the study by Zuo et al. showed that the MIC value
of the isolated active component was 20-times greater
than that of the crude extract [35].
Due to the limited amount of starting material available
it was not possible to test the antimicrobial activity of our
plant extracts on an extensive number of microorganisms.
However, we successfully assessed the in vitro antimicro-
bial activity of these plant extracts against a MRSA strain
(ATCC® BAA-1683, originally isolated from a patient at
the Henry Ford Hospital in 2004) and a variety of Gram-
positive and Gram-negative bacteria. Further investigation
of the antimicrobial activity of these extracts against other
clinical isolates of MRSA is warranted.Conclusion
Our results demonstrate the antimicrobial properties of
R. and U. californica and illustrate their promising anti-
MRSA potential. The findings reported herein give sci-
entific credence to the traditional medicinal uses of these
plants by the indigenous peoples of California and sug-
gest that extracts of R. and U. californica merit further
chemical study as natural antibiotics to identify the sec-
ondary metabolite(s) responsible for their antimicrobial
activity, since such structures could serve as valuable
therapeutic anti-MRSA leads.
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